Odyssey Health, Inc. (0001626644) (Filer) — SEC 8-K Filing
Apr 24, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Johnson & Johnson has acquired AtraVerse Medical, a medical devices business in California. AtraVerse Medical develops the HOTWIRE transseptal access system used in cardiac catheterization procedures, supporting transseptal access for electrophysiology and structural heart workflows. The AtraVerse Medical acquisition expands Johnson & Johnson acquisitions in interventional cardiology and strengthens its portfolio of transseptal access technology for clinicians in CA. The healthcare M&A is categorized as other acquisition and strategic acquisition, with deal size undisclosed and status announced, as Johnson & Johnson pursues a medical devices acquisition to accelerate adoption of its transseptal access offerings.
Filed under
Source
Read full article on prnewswire.comvia GN - entered into definitive agreement · April 24, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Apr 24, 2026
Elite Chiro Group→Joint Corp
Apr 24, 2026
Amperos Health
Apr 24, 2026
MyEyeDr→Lumina Vision Partners
Apr 24, 2026
Welsh Carson Anderson & Stowe→U.S. Anesthesia Partners
Apr 24, 2026